Pau Llàcer

2.4k total citations · 1 hit paper
89 papers, 861 citations indexed

About

Pau Llàcer is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Pau Llàcer has authored 89 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Nephrology. Recurrent topics in Pau Llàcer's work include Heart Failure Treatment and Management (72 papers), Cardiovascular Function and Risk Factors (40 papers) and Electrolyte and hormonal disorders (11 papers). Pau Llàcer is often cited by papers focused on Heart Failure Treatment and Management (72 papers), Cardiovascular Function and Risk Factors (40 papers) and Electrolyte and hormonal disorders (11 papers). Pau Llàcer collaborates with scholars based in Spain, United States and Italy. Pau Llàcer's co-authors include Julio Núñez, Antoni Bayés‐Genís, Gema Miñana, Rafael de la Espriella, Enrique Santas, Patricia Palau, Juan Sanchís, Francisco J. Chorro, Luís Manzano and Vicent Bodı́ and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Pau Llàcer

77 papers receiving 855 citations

Hit Papers

Effect of β-Blocker Withdrawal on Functional Capacity in ... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pau Llàcer Spain 16 677 154 100 96 94 89 861
Rafael de la Espriella Spain 19 909 1.3× 290 1.9× 218 2.2× 143 1.5× 163 1.7× 129 1.2k
Mateusz Sokolski Poland 14 566 0.8× 220 1.4× 116 1.2× 119 1.2× 43 0.5× 42 844
Masatoshi Minamisawa Japan 18 521 0.8× 98 0.6× 133 1.3× 101 1.1× 45 0.5× 59 829
Zach Rozenbaum Israel 15 705 1.0× 170 1.1× 148 1.5× 68 0.7× 27 0.3× 85 872
Jindřich Špinar Czechia 12 616 0.9× 60 0.4× 141 1.4× 53 0.6× 45 0.5× 127 834
Satoru Kishi Japan 18 694 1.0× 99 0.6× 249 2.5× 28 0.3× 79 0.8× 56 991
Wael AlJaroudi United States 21 1.1k 1.6× 76 0.5× 189 1.9× 53 0.6× 26 0.3× 106 1.4k
Kazuaki Wakami Japan 19 844 1.2× 85 0.6× 113 1.1× 23 0.2× 53 0.6× 53 1.0k
Wen‐Chung Yu Taiwan 16 826 1.2× 138 0.9× 152 1.5× 51 0.5× 16 0.2× 64 1.1k
Krista Siirilä‐Waris Finland 12 610 0.9× 138 0.9× 75 0.8× 187 1.9× 23 0.2× 16 760

Countries citing papers authored by Pau Llàcer

Since Specialization
Citations

This map shows the geographic impact of Pau Llàcer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pau Llàcer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pau Llàcer more than expected).

Fields of papers citing papers by Pau Llàcer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pau Llàcer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pau Llàcer. The network helps show where Pau Llàcer may publish in the future.

Co-authorship network of co-authors of Pau Llàcer

This figure shows the co-authorship network connecting the top 25 collaborators of Pau Llàcer. A scholar is included among the top collaborators of Pau Llàcer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pau Llàcer. Pau Llàcer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llàcer, Pau, Rafael de la Espriella, Gema Miñana, et al.. (2025). The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125. European Journal of Internal Medicine. 133. 71–77. 1 indexed citations
2.
Llàcer, Pau, Jorge E. Campos, Carlos Pérez‐Plasencia, et al.. (2025). Pulsatile Arterial Haemodynamic Effect on Renal Outcomes in Patients with Acute Heart Failure. Cardiorenal Medicine. 15(1). 587–594. 1 indexed citations
3.
Llàcer, Pau, Marta Cobo Marcos, Rafael de la Espriella, et al.. (2025). Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors. European Journal of Internal Medicine. 139. 106357–106357.
4.
Rodríguez, José María Fernández, Mar Domingo, Rafael de la Espriella, et al.. (2025). The Chloride Paradigm Shift in Heart Failure: From Neglected ion to Keystone of Precision Diuretic Therapy. European Journal of Heart Failure. 27(12). 3084–3095.
5.
Yun, Sergi, Jesús Casado, José Pérez-Silvestre, et al.. (2024). Sospecha clínica, diagnóstico y seguimiento de la amiloidosis cardíaca: documento de actualización y resumen ejecutivo. Revista Clínica Española. 224(5). 288–299.
6.
Santas, Enrique, Patricia Palau, Pau Llàcer, et al.. (2024). High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure. Scientific Reports. 14(1). 21672–21672. 12 indexed citations
7.
Conde‐Martel, Alicia, Joan Carles Trullàs, José Luís Morales‐Rull, et al.. (2024). Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial. Revista Clínica Española (English Edition). 224(2). 67–76. 6 indexed citations
8.
Pascual‐Figal, Domingo A., Julio Núñez, Teresa Martı́nez, et al.. (2024). Colchicine in acutely decompensated heart failure: the COLICA trial. European Heart Journal. 45(45). 4826–4836. 20 indexed citations
9.
Conde‐Martel, Alicia, Joan Carles Trullàs, Pau Llàcer, et al.. (2024). Prognostic Impact of Statins in Heart Failure with Preserved Ejection Fraction. Journal of Clinical Medicine. 13(19). 5844–5844.
10.
Santas, Enrique, Pau Llàcer, Patricia Palau, et al.. (2023). Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure. Revista Española de Cardiología (English Edition). 77(3). 206–214. 3 indexed citations
11.
Rodríguez, José María Fernández, Jesús Casado, Françesc Formiga, et al.. (2023). Resumen ejecutivo de la actualización 2023 del consenso de actuación básica durante el ingreso hospitalario por insuficiencia cardiaca aguda. Revista Clínica Española. 223(8). 499–509.
12.
Llàcer, Pau, Julio Núñez, M. Fabregate, et al.. (2023). Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction. Clinical Cardiology. 46(8). 906–913. 2 indexed citations
13.
Rodríguez, José María Fernández, Jesús Casado, Françesc Formiga, et al.. (2023). Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure. Revista Clínica Española (English Edition). 223(8). 499–509. 1 indexed citations
14.
Santas, Enrique, Pau Llàcer, Patricia Palau, et al.. (2023). Morbimortalidad no cardiovascular en función de la fracción de eyección del ventrículo izquierdo tras una hospitalización por insuficiencia cardiaca. Revista Española de Cardiología. 77(3). 206–214. 2 indexed citations
15.
Llàcer, Pau, et al.. (2022). Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction. Medicina Clínica (English Edition). 159(4). 164–170. 2 indexed citations
16.
Espriella, Rafael de la, Jorge Navarro, Anna Mollar, et al.. (2022). Long-Term Prognostic Impact of Estimated Glomerular Filtration Rate on Admission in Patients Hospitalized for Acute Heart Failure. Cardiorenal Medicine. 12(4). 179–188. 5 indexed citations
17.
Méndez‐Bailón, Manuel, Françesc Formiga, José Carlos Arévalo‐Lorido, et al.. (2022). Prognostic Significance of the PROFUND Index on One Year Mortality in Acute Heart Failure: Results from the RICA Registry. Journal of Clinical Medicine. 11(7). 1876–1876. 2 indexed citations
18.
Santas, Enrique, Patricia Palau, Pau Llàcer, et al.. (2021). Sex‐Related Differences in Mortality Following Admission for Acute Heart Failure Across the Left Ventricular Ejection Fraction Spectrum. Journal of the American Heart Association. 11(1). e022404–e022404. 15 indexed citations
19.
Yun, Sergi, Cristina Enjuanes, Marta Cobo Marcos, et al.. (2020). Study Design of Heart Failure Events Reduction with Remote Monitoring and eHealth Support (HERMeS). ESC Heart Failure. 7(6). 4448–4457. 8 indexed citations
20.
Núñez, Julio, Eduardo Núñez, Gema Miñana, et al.. (2012). Differential Mortality Association of Loop Diuretic Dosage According to Blood Urea Nitrogen and Carbohydrate Antigen 125 Following a Hospitalization for Acute Heart Failure. European Journal of Heart Failure. 14(9). 974–984. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026